|
Code
|
3005B
|
|
MA number
|
EU/1/00/152/021
|
|
Product Form:
|
plv inu 50(5x10)x0,5 ml + 50(5x10)x0,5 ml (50x liek.+50xstriek.-multibal.)
|
|
MA Status:
|
E - Valid centralised marketing authorisation
|
|
Type of procedure:
|
EU
|
|
MAH, country:
|
GlaxoSmithKline Biologicals S.A., Belgium
|
|
Therapeutic Class:
|
59 - IMMUNOPRAEPARATA
|
|
ATC:
|
| J |
ANTIINFECTIVES FOR SYSTEMIC USE |
| J07 |
VACCINES |
| J07C |
BACTERIAL AND VIRAL VACCINES, COMBINED |
| J07CA |
Bacterial and viral vaccines, combined |
| J07CA09 |
diphtheria-Hemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B |
|
|
Shelf life:
|
36 |
|
Container:
|
glass vial
|
|
Route of admin.:
|
Intramuscular use
|
European Medicines Agency's database
